Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
A. Horwich(Institute of Cancer Research), Emma Hall(Institute of Cancer Research), Sophie D. Fosså(Oslo University Hospital), Sally Stenning(Medical Research Council), Robert Huddart(Institute of Cancer Research), Maria Aresu(Institute of Cancer Research), D.P. Dearnaley(Royal Marsden NHS Foundation Trust), Judith M. Bliss(Institute of Cancer Research)
Cited by 103
Related Papers
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
|UCL Discovery (University College London)|1997|1k
Multiple newly identified loci associated with prostate cancer susceptibility
|Nature Genetics|2008|850